Harnessing hemp: Koru Pharmaceuticals develops K-beauty skin care made with

[ad_1]

Based in Seoul, Koru Pharmaceuticals specialises in anti-ageing medical aesthetic and skin rejuvenation products. Its portfolio includes fillers, bio-revitalization and mesotherapy products, masks, threads and lipolytics.

The firm’s latest brand, Mesohemp, is a skin care range that contain a native Korean species of hemp called green hemp – a hybrid of imported cannabis from the Netherlands and Korean hemp.

Cultured in domestically, the ingredient contains 460 natural substances including Omega 3, 6, 9, and at least 20% cannabidiol (CBD), claims the company.

Koru Pharmaceuticals developed Mesohemp as a response to the tremendous progress of the CBD beauty market.

According to the Beauty Disruptor report by Prohibition Partners, the global cannabidiol CBD skin care market is projected to surge​ to €870.5m U$959m by 2024.

The cannabis market intelligence and consultancy firm predicted that by then, CBD beauty will represent 10% of the total global skin care market.

In November 2018, South Korea’s Narcotics Control Act was amended and use of medical cannabis became legal, making South Korea the first country in East Asia to legalise medical cannabis.

As it stands, current law in allows the import of CBD materials extracted from hemp seeds, stems and roots that do not contain any tetrahydrocannabinol (THC).

Currently, the range consists of six products, including a cream, serum, sun block and facial sheet masks.

The company is intending to extend the range to include more products and is continuing to research on how hemp can be applied.

[ad_2]

Read More: Harnessing hemp: Koru Pharmaceuticals develops K-beauty skin care made with